Raloxifene hydrochloride, a second-generation Selective Estrogen Receptor Modulator (SERM), is primarily used to prevent and treat osteoporosis in postmenopausal women by mimicking the bone-protective effects of estradiol. Unlike tamoxifen, which acts as an anti-estrogen in both breast and bone tissues, it selectively blocks estrogen receptors in breast and uterine tissues while exhibiting estrogen-like activity in bones. This dual function not only aids in maintaining bone density but also helps reduce the risk of invasive breast cancer in high-risk postmenopausal women.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about RALOXIFEX 60 by Euro-Pharmacies, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.